Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic allograft nephropathy.

Pankaj Baluja1, Lukas Haragsim, Zoltan Laszik

  • 1Department of Medicine, University of Oklahoma, Oklahoma City, OK 73104, USA.

Advances in Chronic Kidney Disease
|January 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UNLOCKING MULTI-SAMPLE DIFFERENTIAL EXPRESSION FOR SPATIAL TRANSCRIPTOMICS DATA WITH TESSERA.

bioRxiv : the preprint server for biology·2026
Same author

Case Series of Histopathological Findings in Chronic Kidney Disease: Insights From the Kidney Precision Medicine Project.

Kidney medicine·2026
Same author

Initial Experience of Metabolic Imaging With Hyperpolarized [1-<sup>13</sup>C]pyruvate MRI in Kidney Transplant Patients.

Journal of magnetic resonance imaging : JMRI·2024
Same author

Utility of PD-1, PD-L1, and IDO-1 Stains in Ocular Extranodal Marginal Zone Lymphoma (MZL) and Diffuse Large B-cell Lymphoma (DLBCL).

Applied immunohistochemistry & molecular morphology : AIMM·2024
Same author

A reference tissue atlas for the human kidney.

Science advances·2022
Same author

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.

Annals of transplantation·2021
Same journal

The Physician Leader: Teaching Leadership in Medicine.

Advances in chronic kidney disease·2022
Same journal

Postgraduate Education and Training for the Nephrology Physician Assistants and Nurse Practitioners.

Advances in chronic kidney disease·2022
Same journal

Evaluation Evolution: Designing Optimal Evaluations to Enhance Learning in Nephrology Fellowship.

Advances in chronic kidney disease·2022
Same journal

Kidney Pathology Education for Nephrology Fellows: Past, Present, and Future.

Advances in chronic kidney disease·2022
Same journal

Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience.

Advances in chronic kidney disease·2022
Same journal

Current Trends and Challenges in Nephrology Fellowship Training: Expansion of Education in Home Dialysis, Palliative Care, and Point-of-Care Ultrasound.

Advances in chronic kidney disease·2022
See all related articles

Despite advances in immunosuppression and infection control, long-term transplant survival remains poor. Chronic fibrotic processes, termed chronic allograft nephropathy, are a leading cause of transplant failure.

Area of Science:

  • Nephrology
  • Transplant Immunology
  • Immunosuppression

Background:

  • Calcineurin inhibitors have significantly improved acute rejection rates in solid-organ transplantation.
  • Short-term allograft survival has improved due to advanced diagnostics, potent antirejection drugs, and infection control strategies.

Purpose of the Study:

  • To highlight the persistent challenge of long-term graft loss in solid-organ transplantation.
  • To identify the primary drivers of long-term transplant failure.

Main Methods:

  • Review of advancements in transplant diagnostics and therapeutics over the past two decades.
  • Analysis of factors contributing to long-term allograft survival and failure.

Main Results:

Related Experiment Videos

  • Long-term graft loss rates have remained largely unchanged over the past 20 years.
  • The average half-life of a deceased-donor kidney transplant in the US is approximately one decade.

    • Conclusions:

    • Despite improved acute rejection control, chronic fibrotic processes, including chronic allograft nephropathy, are major contributors to long-term transplant failure.
    • Addressing chronic fibrotic pathways is crucial for improving long-term outcomes in solid-organ transplantation.